Expression of Leukemia-Associated Antigen, JL1, in Bone Marrow and Thymus-Reference-Cited by-同舟云学术

Expression of Leukemia-Associated Antigen, JL1, in Bone Marrow and Thymus

Published:2001-04 Issue:4 Volume:158 Page:1473-1480
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Kee Shin Young,Young Choi Eun,Hyung Kim Seok,Chung Junho,Hyun Chung Doo,Seo Park Weon,Cheon Jung Kyeong,Sik Kim Heung,Park Seonyang,Jin Kim Hee,Hee Park Myoung,Ki Min Chang,Choo Kim Chun,Hoe Park Seong

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference38 articles.

1. Detection of minimal residual disease in acute leukemia: methodologic advances and clinical significance;Compana;Blood,1995

2. Immunotherapy for acute leukemias;Caron;Curr Opin Oncol,1994

3. Monoclonal antibody therapy of leukemia and lymphoma;Jurcic;Adv Pharmacol,1995

4. Advances in immunotherapy of hematologic malignancies;Maloney;Curr Opin Hematol,1998

5. Advances in the immunotherapy of hematologic malignancies: cellular and humoral approaches;Maloney;Curr Opin Hematol,1999

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. JL1 Antigen Expression on Bone Marrow Lymphoma Cells from Patients With Non-Hodgkin Lymphoma;Annals of Laboratory Medicine;2020-01-01

2. Use of the JL1 Epitope, Which Encompasses the Nonglycosylation Site of CD43, as a Marker of Immature/Neoplastic Langerhans Cells;American Journal of Surgical Pathology;2012-08

3. Expression of the promyelocytic leukemia zinc-finger in T-lymphoblastic lymphoma and leukemia has strong implications for their cellular origin and greater association with initial bone marrow involvement;Modern Pathology;2012-05-04

4. Expression of JL1 in Burkitt lymphoma is associated with improved overall survival;Virchows Archiv;2011-08-04

5. Targeting of a developmentally regulated epitope of CD43 for the treatment of acute leukemia;Cancer Immunology, Immunotherapy;2011-06-28